awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q26771331-7F42BB50-F6C2-479D-B697-E2A679DD7026
Q26771331-7F42BB50-F6C2-479D-B697-E2A679DD7026
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771331-7F42BB50-F6C2-479D-B697-E2A679DD7026
Evolving paradigms in the treatment of relapsed/refractory multiple myeloma: increased options and increased complexity
P2860
Q26771331-7F42BB50-F6C2-479D-B697-E2A679DD7026
BestRank
Statement
http://www.wikidata.org/entity/statement/Q26771331-7F42BB50-F6C2-479D-B697-E2A679DD7026
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
47005d31ef49ca0433a0832cc4bdf79e5744486c
P2860
Pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone alone for patients with relapsed and refractory multiple myeloma (MM-003): a randomised, open-label, phase 3 trial.